biomedicina slovenica

re="Cancer" : 108-207

  1. Pompe-Kirn V; Primic-Žakelj M
    An epidemiological analysis of bladder cancer in Slovenia
    1987 ►
  2. Ravnihar B; Pompe-Kirn V
    Multiple primary cancers as recorded by the cancer registry of Slovenia - a problem of reliability
    1974 ►
  3. Zwitter M; Pompe-Kirn V; Primic-Žakelj M
    Pregnancy and Hodgkin's disease
    1989 ►
  4. Pompe-Kirn V; Ferligoj A
    Solving the problem of small population based areas for the analysis of rare diseases by clustering with constraints methods
    1989 ►
  5. Nicula Florian A.; Anttila Ahti; Neamtiu Luciana; Primic-Žakelj Maja; Tachezy Ruth; Chil Arkadiusz; Grce Magdalena; Kesić Vesna
    Challenges in starting organised screening programmes for cervical cancer in the member states of the European Union
    2009 ►
  6. Ronco Guglielmo; van Ballegoijen Marjolein; Becker Nicolas; Rebolj Matejka; Primic-Žakelj Maja
    Process performance of cervical screening programmes in Europe
    2009 ►
  7. Stare Janez
    Goodness of fit of relative survival regression models
    2009 ►
  8. Stare Janez
    A new measure of explained variation for survival models
    2009 ►
  9. Mlakar Vid; Berginc Gašper; Volavšek Metka; Štor Zdravko; Rems Miran; Glavač Damjan
    Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer
    2009 ►
  10. Tomaževič Tanja; Jazbec Janez
    Controlled, randomised, double-blinded study of prevention and treatment of oralmucositis with propolis
    2009 ►
  11. Bešić Nikola; Vidergar-Kralj Barbara; Žagar Ivana
    Radioiodine in therapy of patients with Hürthle cell carcinoma of the thyroid
    2009 ►
  12. Snoj Nataša; Bedard Philippe L.; De Azambuja Evandro; Cardoso Fatima; Piccart Martine
    Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
    2009 ►
  13. Škof Erik; Reberšek Martina; Hlebanja Zvezdana; Ocvirk Janja
    Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial
    2009 ►
  14. Tevž Gregor; Pavlin Darja; Kamenšek Urška; Kranjc Simona; Vidic Suzana; Cör Andrej; Serša Gregor; Čemažar Maja
    Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression
    2008 ►
  15. Golouh R; Čufer T; Sadikov A; Nussdorfer P; Usher PA; Brunner N; Schmitt M; Lesche R; Maier S; Timmermans M; Foekens JA; Martens JW
    The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study
    2008 ►
  16. Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    2009 ►
  17. Zhang Yi; Sieuwerts Anieta M; McGreevy Michelle; Casey Graham; Čufer Tanja; Paradiso Angelo; Harbeck Nadia; Span Paul N; Hicks David G; Golouh Rastko
    The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
    2009 ►
  18. Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Lindtner J; Čufer T
    Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
    2009 ►
  19. Cardoso F; Bedard PL; Winer EP; Pagani O; Senkus-Konefka E; Fallowfield LJ; Kyriakides S; Costa A; Čufer T; Albain KS
    International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
    2009 ►
  20. Snoj N; Čufer T
    Two faces of screen detected cancers
    2009 ►
  21. Ravnik M; Sadikov A; Snoj N; Nussdorfer P; Čufer T
    Validation of Adjuvant online on Slovenian collective of hormone receptor (HR) positive early breast cancer patients
    2009 ►
  22. Stražišar Mojca; Glavač Damjan
    Genetics of sporadic and hereditary colorectal cancer: implications for molecular diagnostics and genetic counseling
    2009 ►
  23. Kočevar N; Odreman-Macchioli F; Vindigni A; Frković-Grazio S; Balažic J; Komel R
    Identification of biomarkers in gastric edenocarcinoma
    2009 ►
  24. Karina M; Čufer Tanja
    Preliminary safety data of the EORTC 10994/BIG 00-01 neoadjuvant trial comparing 3 cycles of docetaxel followed by 3 cycles of epirubicin-docetaxel versus 6 cycles of FEC 100 in patients with locally advanced/inflammatory or large operable breast cancer
    2006 ►
  25. Golouh Rastko; Čufer Tanja; Sadikov A; Nusdorfer P; Usher P; Bruenner N; Schmitt M; Harbeck N; Lesche R; Meier S
    Stathmin-1 protein expression is associated with disease recurrence in tamoxifen-treated steroid hormone receptor positive early breast cancer: an immunohistochemical study
    2006 ►
  26. Uršič-Vrščaj Marjetka; Rakar Stelio; Možina Andrej; Takač Iztok; Smrkolj Špela
    Clinical audit of patients with cervical cancer
    2006 ►
  27. Macias Vicky; Geynisman Julia; Frković-Grazio Snježana; Bračko Matej; Sušnik Barbara; Lu Yi; Kajdacsy-Balla Andre A; Lindholm Paul F
    Tissue factor (TF) expression in primary invasive breast cancer correlates with tumor size and grade but not with outcome
    2009 ►
  28. Žgajnar J
    Breast conserving surgery
    2003 ►
  29. Žgajnar Janez
    Surgical management of nonpalpable breast lesions
    2003 ►
  30. Strojan Primož; Zadravec-Zaletel Lorna; Anžič Jožica; Korenjak Roman; Jereb Berta
    The role of radiotherapy in the treatment of childhood intracranial germinoma: long-term survival and late effects
    2006 ►
  31. Chuang Shu-Chun; Pompe-Kirn Vera
    Risk of second primary cancer among esophageal cancer patients: #a #pooled analysis of 13 cancer registries
    2008 ►
  32. Velenšek Veronika; Mazič Uroš; Kržišnik Ciril; Demšar Damjan; Jazbec Janez; Jereb Berta
    Cardiac damage after treatment of childhood cancer: a long-term follow-up
    2008 ►
  33. Munch-Petersen Birgitte; Piškur Jure
    Deoxynucleoside kinases and their potential role in deoxynucleoside cytotoxicity
    2006 ►
  34. Stražišar M; Mlakar V; Rott T; Glavač D
    Somatic alterations of the serine/threonine kinase LKB1 gene in squamous Cell (SCC) and large cell (LCC) lung carcinoma
    2009 ►
  35. Lusa Lara
    Challenges in transporting multigene classifiers to the clinic
    2008 ►
  36. Celhar Teja; Geršak Ksenija; Ovčak Zdenka; Sedmak Boris; Mlinarič-Raščan Irena
    The presence of the CYP11A1 (TTTTA)6 allele increases the risk of biochemical relapse in organ confined and low-grade prostate cancer
    2008 ►
  37. Ravnihar B; Pompe-Kirn V
    Yugoslavia, Slovenia
    1976 ►
  38. Chuang Shu-Chun; Pompe-Kirn Vera
    Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries
    2008 ►
  39. Stražišar Mojca; Mlakar Vid; Glavač Damjan
    LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma
    2009 ►
  40. Čufer Tanja; Pajk Bojana; Borštnar Simona
    Individualised systemic treatment
    2006 ►
  41. Viale Giuseppe; Golouh Rastko
    Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
    2008 ►
  42. Pavlin Darja; Tozon Nataša; Serša Gregor; Pogačnik Azra; Čemažar Maja
    Efficient electrotransfection into canine muscle
    2008 ►
  43. Korošec Branka; Glavač Damjan; Volavšek Metka; Ravnik-Glavač Metka
    Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma
    2008 ►
  44. Berne S; Španinger K; Komel R; Debeljak N
    Molecular mechanism of recombinant human erythropoietin action on cancer cells
    2008 ►
  45. Feldman Laurie; Jeong Jee-Yeong; Davis Kerry L; Socha Amanda L; Španinger Klemen; Sytkowski Arthur
    Role of the erythropoietin receptor in breast cancer pathobiology
    2008 ►
  46. Lah-Turnšek Tamara; Duran-Alonso Beatriz M; Gole Boris; Kenig Saša; Pucer Anja; Ardebili Youssuf; Dolenc Vincenc
    SIgnalling of the lysosomal proteases cathepsins B and L in regulating glioma progression
    2008 ►
  47. Filipič Metka; Plazar Janja; Žegura Bojana; Lah Tamara T; Groothuis Geny MM; Ferk Franziska; Huber Wolfgang W; Kansmueller Siegfried
    Xanthohumol from hop (Humulus lupulus L) and beer: a promisiing natural cancer preventive compound
    2008 ►
  48. de Haas T; Hasselt N; Troost D; Caron H; Popović M; Zadravec-Zaletel L; Grajkowska W; Perek M; Osterheld MC; Ellison D
    Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression
    2008 ►
  49. Omejc Mirko; Mekicar Jernej
    Computer analysis of lymph nodes in gastric cancer surgery
    2008 ►
  50. Stražišar Mojca; Rott Tomaž; Glavač Damjan
    Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer
    2009 ►
  51. Bizjak-Ogrinc Urška; Čufer Tanja; Pompe-Kirn Vera
    Survival of patients with invasive urinary bladder cancer in Slovenia regarding to stage of disease and treatment in years 1987-1997
    2007 ►
  52. Pompe-Kirn V; Zakotnik B; Volk N; Benulič T; Škrk J
    Cancer patients survival in Slovenia, 1963-1990
    1995 ►
  53. Ravnihar B; Pompe-Kirn V
    Experiences of the cancer registry in Slovenia
    1975 ►
  54. Cappelletti V; Gariboldi M; De Cecco; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
    Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer
    2008 ►
  55. Ravnik Maja; Takač Iztok; Arko Darja; Gorišek Borut; Čas-Sikošek Nina; Lampelj Maja; Ravnik Janez; Čufer Tanja
    Expression of invasive markers (uPA/PAI-1) in four different HER2, ER, PR subgroups of early breast cancer
    2008 ►
  56. Lusa L
    Discovery and validation of cancer subtypes using high-throughput technologies
    2007 ►
  57. Serša Gregor; Jarm Tomaž; Kotnik Tadej; Cör Andrej; Podkrajšek Maja; Šentjurc Marjeta; Miklavčič Damijan; Kadivec Maksimiljan; Kranjc Simona; Šečerov Ajra; Čemažar Maja
    Vascular disrupting action of electroporatin and electrochemotherapy with bleomycin in murine sarcoma
    2008 ►
  58. Zielinski Christoph C.; Awada Ahmad; Cameron David A.; Čufer Tanja; Martin Miguel; Aapro Matti S.
    The impact of new European organisation for research and treatment of cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients
    2008 ►
  59. Lusa Lara; Peissel Bernard; Manoukian Siranoush; Marchesi Edoardo; Radice Paolo; Pierotti Marco A; Gariboldi Manuela
    Re: Molecular basis for estrogen receptor alpha deficiency in BRCA 1-linked breast cancer
    2008 ►
  60. Možina A; Uršič-Vrščaj M; Takač I; Meglič L; Smrkolj Š; Rakar S
    Clinical audit of patients with cervical cancer in Slovenia - data analysis for the year 2003 and 2004
    2006 ►
  61. Meglič L; Možina A; Verdenik I
    Cytology quality in the national cervical screening program in Slovenia
    2006 ►
  62. Frattini M; Gallino G; Signoroni S; Balestra D; Lusa L; Battaglia L; Sozzi G; Bertario L; Leo E; Pilotti S; Pierotti MA
    Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
    2008 ►
  63. Hočevar Marko; Auersperg Marija
    Use of serum thyroglobulin for monitoring the effect of chemotherapy and irradiation in differentiated thyroid cancer
    1995 ►
  64. Auersperg Marija; Us-Krašovec Marija; Pogačnik Ana; Hočevar Marko; Palčič Branko; Garner D
    Vinblastine (VBL) in differentiated thyroid carcinoma (DTC) effect monitored by DNA measurements
    1995 ►
  65. Debrakeleer S.; De Greve Jacques; Krajc Mateja; Sermijn E.; Fontaine C.; Goelen Guido; Bonduelle M.; Novaković Srdjan; Teugels Erik
    Germline mutation of the BARD1 ankyrin domain in a non-BRCA1/2 breast cancer family
    2006 ►
  66. Možina Andrej; Uršič-Vrščaj Marjetka; Takač Iztok; Meglič Leon; Smrkolj Špela; Rakar Stelio
    Clinical audit of patients with cervical cancer in Slovenia - data analysis for the years 2003 and 2004
    2006 ►
  67. Albreht Tit; McKee Martin; Alexe Delia-Marina; Coleman Michel P; Martin-Moreno Jose M
    Making progress against cancer
    2008 ►
  68. Alexe Delia-Marina; Albreht Tit; McKee Martin; Coleman Michel P
    Responding to the challenge of cancer in Europe
    2008 ►
  69. Rokavec Matjaž; Justenhoven Christina; Schroth Werner; Istrate Monica Adina; Haas Susanne; Fischer Hans-Peter; Vollmert Caren; Illig Thomas; Hamann Ute; Ko Yon-Dschun; Glavač Damjan; Brauch Hiltrud
    A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk
    2007 ►
  70. Cataliotti L.; Čufer Tanja
    Guidelines on the standards for the training of specialised health professionals dealing with breast cancer
    2007 ►
  71. Lusa Lara; Mc Shane Lisa M; Reid James F; De Cecco Loris; Ambrogi Federico; Biganzoli Elia; Gariboldi Manuela; Pierotti Marco A
    Challenges in projecting clustering results across gene expression profiling data sets
    2007 ►
  72. Mezzanzanica Delia; Fabbi Marina; Bagnoli Marina; Staurengo Samantha; Losa Marco; Balladore Emanuela; Alberti Paola; Lusa Lara; Ditto Antonino; Ferrini Silvano
    Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients
    2008 ►
  73. Debevec Lučka; Debeljak Andrej
    Outcomes of unselected routinely treated lung cancer patients
    2008 ►
  74. Menvielle G; Kunst AE; Stirbu I; Strand BH; Borrell C; Regidor E; Leclerc A; Esnaola S; Bopp M; Lundberg O; Artnik B; Costa G; Deboosere P; Martikainen P; Mackenbach JP
    Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe
    2008 ►
  75. Reid James F; Lusa Lara; De Cecco Loris; Coradini Danila; Veneroni Silvia; Daidone Maria Grazia; Gariboldi Manuela; Pierotti Marco A
    Re:Limits of predictive models using microarray data for breast cancer clinical treatment outcome: resoponse
    2005 ►
  76. Reid James F; Lusa Lara; De Cecco Loris; Coradini Danila; Veneroni Silvia; Daidone Maria Grazia; Gariboldi Manuella; Pierotti Marco A
    Limits of predictive models using microarray data for breast cancer clinical treatment outcome
    2005 ►
  77. Lusa Lara; McShane Lisa M; Reid James F; De Cecco Loris; Ambrogi Federico; Biganzoli Elia; Gariboldi Manuela; Pierotti Marco A
    Challenges in projecting clustering results across gene expression-profiling datasets
    2007 ►
  78. Injac Rade; Perše Martina; Bošković Marija; Djordjević Milić Vukosava; Djordjević Aleksandar; Hvala Anastazija; Cerar Anton; Štrukelj Borut
    Cardioprotective effects of fullerenol c60(oh)24 on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm
    2008 ►
  79. Eržen M; Smrkolj S; Rakar S; Stržinar V
    Stage IA cervical carcinoma: disease outcome of 566 cases
    2007 ►
  80. Debevec Lučka
    Do patients have less thoracic pain from lobectomy compared to pneumonectomy?
    2007 ►
  81. Tuohimaa P; Pukkala E; Scelo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V
    Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation
    2007 ►
  82. Maule M; Scelo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; Pompe-Kirn V
    Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study
    2007 ►
  83. Riska A; Pukkala E; Scelo G; Mellemkjaer L; Hemminki K; Weiderpass E; McBride ML; Pompe-Kirn V; Tracey E; Brewster DH
    Second primary malignancies in females with primary fallopian tube cancer
    2007 ►
  84. Scelo G; Boffetta P; Corbex M; Chia KS; Hemminki K; Friis S; Pukkala E; Weiderpass E; McBride ML; Pompe-Kirn V
    Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries
    2007 ►
  85. Richiardi L; Scelo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; Pompe-Kirn V
    Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries
    2007 ►
  86. Španinger Klemen; Berne Sabina; Komel Radovan; Debeljak Nataša
    Recombinant human erythropoietin induced changes in signal transduction and gene expression in breast cancer patients
    2007 ►
  87. Lah Tamara
    Proteases as targets in brain tumour progression
    2007 ►
  88. Podgornik H; Debeljak M; Žontar D; Černelč P; Prestor VV; Jazbec J
    RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia
    2007 ►
  89. Marty Michel; Serša Gregor; Snoj Marko; Miklavčič Damijan; Pavlović Ivan; Paulin-Košir Marija Snežna; Čemažar Maja; Rudolf Zvonimir
    Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases : results of ESOPE (European standard operating procedures of electrochemotherapy) study
    2006 ►
  90. Snoj Marko; Rudolf Zvonimir; Paulin-Košir Marija Snežna; Čemažar Maja; Snoj Rudolf; Serša Gregor
    Long lasting complete response in melanoma treated by electrochemotherapy
    2006 ►
  91. Serša Gregor
    The state-of-the-art of electrochemotherapy before the ESOPE study : advantages and clinical uses
    2006 ►
  92. Mir Lluis Maria; Gehl J; Serša Gregor; Collins Christopher G.; Garbay JR; Billard Valérie; Geertsen PF; Rudolf Zvonimir; O'Sullivan Gerald C; Marty Michel
    Standard operating procedures of the electrochemotherapy : instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator TM by means of invasive or non-invasive electrodes
    2006 ►
  93. Morales Leilani; Čufer Tanja
    Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer : a randomised phase III trial of the European Organis[!]ation for Research and Treatment of Cancer Breast Group
    2007 ►
  94. Kanthou Chryso; Kranjc Simona; Serša Gregor; Tozer Gillian M; Županič Anže; Čemažar Maja
    The endothelial cytoskeleton as a target of electroporation-based therapies
    2006 ►
  95. Regan Meredith M.; Golouh Rastko
    Re-evaluating adjuvant breast cancer trials : assessing hormone receptor status by immunohistochemical versus extraction assays
    2006 ►
  96. Šuput Dušan; Živin-Milutinović Aleksandra
    Tumour promotion, carcinogenesis or adaptive regeneration in rat liver after chronic intoxication with microcystin-LR?
    2006 ►
  97. Grmek Marko; Milčinski Metka; Fettich Jurij; Brecelj Janez
    Radiation exposure of hemophiliacs after radiosynoviorthesis with 186Re colloid
    2007 ►
  98. Jazbec Janez; Todorovski Ljubčo; Jereb Berta
    Classification tree analysis of second neoplasms in survivors of childhood cancer
    2007 ►
  99. Debeljak M; Podkrajšek KT; Aplenc R; Jazbec J
    X-linked lymphoproliferative disease with a novel SH2D1A gene mutation
    2008 ►
  100. Lanišnik-Rižner T; Šmuc T; Bajc G; Kristan K; Šinkovec T
    Aberrant pre-receptor regulation in endometrial cancer
    2006 ►

   1 8 108 208 308 408 508 608 708  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics